메뉴 건너뛰기




Volumn 13, Issue 10, 2005, Pages 812-818

Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: A retrospective analysis of three clinical trials

Author keywords

Adherence to protocol therapy; Emesis; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GEMCITABINE; PACLITAXEL;

EID: 26244461049     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0803-x     Document Type: Article
Times cited : (32)

References (8)
  • 2
    • 4243170117 scopus 로고    scopus 로고
    • Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy
    • Ballatori E, Roila F (2003) Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes 1:46
    • (2003) Health Qual Life Outcomes , vol.1 , pp. 46
    • Ballatori, E.1    Roila, F.2
  • 3
    • 0035868896 scopus 로고    scopus 로고
    • Equivalence of three or four cycles of bleomycine, etoposide and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and The Medical Research Council
    • De Wit R, Roberts T, Wilkinson P et al (2001) Equivalence of three or four cycles of bleomycine, etoposide and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and The Medical Research Council. J Clin Oncol 19:1629-1640
    • (2001) J Clin Oncol , vol.19 , pp. 1629-1640
    • De Wit, R.1    Roberts, T.2    Wilkinson, P.3
  • 4
    • 0642347625 scopus 로고    scopus 로고
    • Why do we need another antiemetic? Just ask
    • Kris MK (2003) Why do we need another antiemetic? Just ask. (editorial) J Clin Oncol 21(22):4077-4080
    • (2003) J Clin Oncol , vol.21 , Issue.22 , pp. 4077-4080
    • Kris, M.K.1
  • 5
    • 0034600305 scopus 로고    scopus 로고
    • Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three year results
    • Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E et al (2000) Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three year results. J Natl Cancer Inst 92:699-708
    • (2000) J Natl Cancer Inst , vol.92 , pp. 699-708
    • Piccart, M.J.1    Bertelsen, K.2    James, K.3    Cassidy, J.4    Mangioni, C.5    Simonsen, E.6
  • 6
    • 0037258090 scopus 로고    scopus 로고
    • Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control
    • Schnell FM (2003) Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. The Oncologist 8:187-198
    • (2003) The Oncologist , vol.8 , pp. 187-198
    • Schnell, F.M.1
  • 7
    • 0346560025 scopus 로고    scopus 로고
    • Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975
    • Smit EF, van Meerbeeck PAM, Lianes P, Debruyne C, Legrand C, Schramel F, Smit H, Gaafaar R, Biesma B, Manegold C, Neymark N, Giaccone G (2003) Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975. J Clin Oncol 21:3909-3917
    • (2003) J Clin Oncol , vol.21 , pp. 3909-3917
    • Smit, E.F.1    Van Meerbeeck, P.A.M.2    Lianes, P.3    Debruyne, C.4    Legrand, C.5    Schramel, F.6    Smit, H.7    Gaafaar, R.8    Biesma, B.9    Manegold, C.10    Neymark, N.11    Giaccone, G.12
  • 8
    • 0033855945 scopus 로고    scopus 로고
    • Economics and health-related quality of life in antiemetic therapy: Recommendations for trial design
    • Uyl-de-Groot CA, Wait S, Buijt I (2000) Economics and health-related quality of life in antiemetic therapy: recommendations for trial design. Eur J Cancer 36:1522-1535
    • (2000) Eur J Cancer , vol.36 , pp. 1522-1535
    • Uyl-de-Groot, C.A.1    Wait, S.2    Buijt, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.